Facts about high blood pressure

About 100 million people in Europe suffer from high blood pressure conditions, also known as hypertension. The epidemic spread of this disease owes much to the fact that, until now, the causes of high blood pressure have not been fully understood.

 

Conventional medicine concedes that in most patients the cause of high blood pressure is unknown. A special ‘diagnosis’ is even being used to mask that fact. For millions of patients the term ‘essential hypertension’ suggests a precise diagnosis — in reality it is the code within the medical profession for ‘we don’t know.’

Thus, conventional pharmaceutical-oriented medicine is essentially limited to treating the symptoms of this disease. So-called ACE (angiotensin-converting enzyme) inhibitors, betablockers, diuretics and other high blood pressure medications can artificially lower the blood pressure. These drugs address symptoms without correcting the root cause of the problem.

 

Modern scientific understanding provides logical answers: the primary cause of hypertension is a deficiency of vitamins and micronutrients in the small muscle cells (smooth muscle cells) building up the artery walls regulating the tension of the blood vessel wall and, thereby, the blood pressure.

• Increasing relaxing factors

Among other functions, these cells are responsible for producing ‘relaxing factors‘ (nitric oxide), which decrease vascular wall tension and keep the blood pressure in normal range. Thus, increasing the production of these relaxing factors is an important target for preventing high blood pressure.

• Decreasing constriction factors

Another key regulator of artery wall tension is angiotensin. The active hormone angiotensin II contributes to the regulation of our body fluids. Its overproduction leads to a constriction of the artery walls and to elevated blood pressure.

The angiotensinconverting enzyme (ACE) converts the inactive angiotensin I hormone into the active hormone that constricts the blood vessel wall and increases blood pressure. Lowering the activity of ACE is therefore desirable to normalize high blood pressure. The Dr. Rath Research Institute investigated a composition of vitamins and other micronutrients for their efficacy to affect both of these mechanisms. Based on the research results obtained with this micronutrient composition, the Patent Office allowed the following statements to be made in connection with high blood pressure conditions: